Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 EUR | +0.39% |
|
+1.36% | -24.09% |
Jun. 03 | Transgene: first patient in phase II study | CF |
Apr. 10 | Transgene: presents vaccine results at AACR | CF |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
113M | - | |||||
121B | ||||||
110B | ||||||
25.98B | - | |||||
19.27B | - | |||||
15.99B |
- Stock Market
- Equities
- TNG Stock
- Charts Transgene
- Sector Chart